Carbomenu has protein expression platform in both prokaryotic cells (E.coil) and eukaryotic cells (Yeast/CHO-k1/293). Carbomenu is able to deal with kilogram level customized protein production orders. Our product line can be optimized according to customer orders to meet personalized needs.
Carbomenu can supply Carbohydrates such as Monosaccharides Maltooligosaccharides which are our superior products.
Carbomenu can supply BFGF, PDGFB and IGF1 for cultured meat industry. Carbomeu can enzymes such as DNase I, Poly(A) Polymerase, RNase Inhibitor, PPase, T7 RNA Polymerase, mRNA Vaccinia Capping Enzyme and mRNA Cap 2'-O-MTase for mRNA vaccines industry.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Lane561 Xiuchuan Rd.greenland Max-Mall,shanghai,201200, P.r.china, Shanghai,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.carbomenu.com
- HQ
- Shanghai
Carbomenu Questions
Carbomenu's website is http://www.carbomenu.com
Carbomenu's LinkedIn profile is https://cn.linkedin.com/company/carbomenu
Carbomenu has
1 employees.
View email and phone details for 1
employees at Carbomenu.
Carbomenu's industry is
Biotechnology Research
Carbomenu's top competitors are
Alkimia Conscious Capital,
National Institute For Cellular Agriculture,
Canaille,
Daewa,
8 Food Syndicate,
Botfood,
Naparra Blending, S.l.,
Asymmetrics Research,
M-Pure,
Nytroponix.
Carbomenu's categories are Biotechnology Research
Carbomenu's founding year is 2018
